Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
866.43B
Market cap866.43B
Price-Earnings ratio
38.63
Price-Earnings ratio38.63
Dividend yield
0.70%
Dividend yield0.70%
Average volume
3.18M
Average volume3.18M
High today
$924.14
High today$924.14
Low today
$890.00
Low today$890.00
Open price
$893.50
Open price$893.50
Volume
1.99M
Volume1.99M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $917.03, with a market capitalization of 866.43B. The stock trades at a price-to-earnings (P/E) ratio of 38.63 and offers a dividend yield of 70.3%.

As of 2026-03-31, Eli Lilly(LLY) stock has fluctuated between $890.00 and $924.14. The current price stands at $917.03, placing the stock +3.0% above today's low and -0.8% off the high.

Eli Lilly(LLY) shares are trading with a volume of 1.99M, against a daily average of 3.18M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

TipRanks 2h
Lonza Strengthens Board With Nomination of Former Eli Lilly Executive Stephen Fry

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4h
Alkermes jumps after Eli Lilly acquires peer Centessa

Shares of Alkermes (ALKS) ALKS) are moving higher after Eli Lilly (LLY) reached an agreement to acquire Centessa (CNTA) for up to $7.8B. Alkermes, like Centessa...

Benzinga 5h
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

Acquisition Expands Eli Lilly’s Neuroscience Portfolio The acquisition aims to enhance Lilly’s neuroscience portfolio, particularly in sleep medicine, as it se...

Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

CNBC 5h
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Eli Lilly has agreed to pay...

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Nasdaq 5h
Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company

(RTTNews) - Shares of Centessa Pharmaceuticals plc (CNTA) are climbing about 45 percent on Tuesday morning trading after Eli Lilly and Company announced an agre...

Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company
Investor's Business Daily 6h
Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket

Technology Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket Licensing Eli Lilly (LLY) said Tuesday it would buy sleep-wake dis...

Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket
MarketWatch 7h
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this ti...

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
The Wall Street Journal 9h
Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion

Eli Lilly has agreed to buy clinical-stage company Centessa Pharmaceuticals for an initial $6.3 billion in a deal that expands the drugmaker’s neuroscience port...

Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion
TipRanks 9h
Eli Lilly to acquire Centessa for $38.00 per share in cash plus one CVR

Eli Lilly (LLY) and Centessa (CNTA) announced a definitive agreement for Lilly to acquire Centessa. Under the terms of the transaction agreement, Lilly will acq...

Simply Wall St 12h
Eli Lilly’s AI Drug Pact With Insilico And What It Means For Valuation

Eli Lilly (NYSE: LLY) has signed a global AI drug discovery partnership with Insilico Medicine. The agreement covers multiple disease areas, with potential dea...

Eli Lilly’s AI Drug Pact With Insilico And What It Means For Valuation

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.